Detalles de la búsqueda
1.
Long-term prospective outcome data using EndoPredict as risk stratification and chemotherapy decision biomarker in hormone receptor-positive, HER2-negative early breast cancer.
Breast Cancer Res Treat
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38722442
2.
Microsurgical training curriculum in a gynecological breast cancer center: a benefit for patients and surgeons?
Arch Gynecol Obstet
; 309(1): 281-286, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37644236
3.
Omega-3 polyunsaturated fatty acids improve intestinal barrier integrity-albeit to a lesser degree than short-chain fatty acids: an exploratory analysis of the randomized controlled LIBRE trial.
Eur J Nutr
; 62(7): 2779-2791, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37318580
4.
Incidence and predictors for chemotherapy modifications and their impact on the outcome of ovarian cancer patients.
Arch Gynecol Obstet
; 307(6): 1891-1899, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36326848
5.
Intracavitary brachytherapy with additional Heyman capsules in the treatment of cervical cancer.
Arch Gynecol Obstet
; 307(2): 557-564, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35639163
6.
CXCL9 inhibits tumour growth and drives anti-PD-L1 therapy in ovarian cancer.
Br J Cancer
; 126(10): 1470-1480, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35314795
7.
Platelet mitochondrial membrane depolarization reflects disease severity in patients with preeclampsia.
Mol Med
; 28(1): 51, 2022 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35508969
8.
Distress in hospitalized cancer patients: Associations with personality traits, clinical and psychosocial characteristics.
Psychooncology
; 31(5): 770-778, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34894364
9.
Physical activity and Mediterranean diet as potential modulators of osteoprotegerin and soluble RANKL in gBRCA1/2 mutation carriers: results of the lifestyle intervention pilot study LIBRE-1.
Breast Cancer Res Treat
; 190(3): 463-475, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34570303
10.
Precursor fractions of neurotensin and enkephalin might point to molecular mechanisms of cancer risk modulation during a lifestyle-intervention in germline BRCA1/2 gene mutation carriers.
Breast Cancer Res Treat
; 186(3): 741-752, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33543354
11.
A multicentre analytical comparison study of inter-reader and inter-assay agreement of four programmed death-ligand 1 immunohistochemistry assays for scoring in triple-negative breast cancer.
Histopathology
; 78(4): 567-577, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32936950
12.
Lifestyle modifications after the diagnosis of gynecological cancer.
BMC Womens Health
; 21(1): 260, 2021 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34182983
13.
Demand for integrative medicine among women with breast and gynecological cancer: a multicenter cross-sectional study in Southern and Northern Germany.
Arch Gynecol Obstet
; 303(5): 1315-1330, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33263787
14.
TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge.
Arch Gynecol Obstet
; 303(6): 1557-1567, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33245408
15.
Breast cancer risk in BRCA1/2 mutation carriers and noncarriers under prospective intensified surveillance.
Int J Cancer
; 146(4): 999-1009, 2020 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31081934
16.
Cancer surveillance and distress among adult pathogenic TP53 germline variant carriers in Germany: A multicenter feasibility and acceptance survey.
Cancer
; 126(17): 4032-4041, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32557628
17.
Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients.
Mol Med
; 26(1): 19, 2020 02 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32028882
18.
First prospective outcome data for the second-generation multigene test Endopredict in ER-positive/HER2-negative breast cancer.
Arch Gynecol Obstet
; 302(6): 1461-1467, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32902674
19.
High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer.
Breast Cancer Res Treat
; 175(1): 217-228, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30725383
20.
Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer.
BMC Cancer
; 19(1): 696, 2019 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31307411